Ventas (VTR) CFO exercises 33,591 options, sells at $76.77

Ventas (VTR) Form 4: EVP & CFO Robert F. Probst exercised stock options for 33,591 shares at $73.71 on 11/12/2025 and sold 33,591 shares at a weighted average price of $76.7719, pursuant to a Rule 10b5-1 trading plan entered on February 19, 2025.

Rhea-AI Filing Summary

Ventas (VTR) Form 4: EVP & CFO Robert F. Probst exercised stock options for 33,591 shares at $73.71 on 11/12/2025 and sold 33,591 shares at a weighted average price of $76.7719, pursuant to a Rule 10b5-1 trading plan entered on February 19, 2025.

The options were fully vested, scheduled to expire within the next nine months, and relate to an award first exercisable on 08/03/2016 with an expiration date of 08/03/2026. Following the transactions, Probst directly beneficially owns 168,364 shares. The sale occurred across multiple trades at prices ranging from $76.71 to $76.9376.

Insider Trade Summary

Exercise and Sale: 33,591 shares ($103K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Probst Robert F

Role EVP and CFO

Sold 33,591 shs ($2.58M)

Approx. gross sale proceeds $2.58M

Approx. exercise cost $2.48M

Approx. pre-tax spread $103K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	33,591	$0.00	$0.00
Exercise	Common Stock	33,591	$73.71	$2.48M
Sale	Common Stock	33,591	$76.7719	$2.58M

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 168,364 shares (Direct)

Footnotes (3)

1. F1. The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025.
2. F2. The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $76.71 to $76.9376 inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. Fully vested.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Ventas (VTR) report?

The EVP & CFO exercised 33,591 stock options at $73.71 and sold 33,591 shares at a weighted average price of $76.7719 on 11/12/2025.

Was the Ventas (VTR) CFO trade under a Rule 10b5-1 plan?

Yes. The transactions were made pursuant to a Rule 10b5-1 trading plan entered on February 19, 2025.

How many Ventas (VTR) shares does the CFO own after the trade?

Following the reported transactions, the CFO directly beneficially owns 168,364 shares.

What was the price range for the Ventas (VTR) share sales?

Sales occurred in multiple transactions at prices ranging from $76.71 to $76.9376.

What were the terms of the exercised options at Ventas (VTR)?

Options for 33,591 shares at an exercise price of $73.71; fully vested, first exercisable on 08/03/2016 and expiring on 08/03/2026.

Why did the Ventas (VTR) CFO exercise the options now?

Footnotes state the options were fully vested and scheduled to expire within the next nine months.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/14/2025 - 05:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Probst Robert F

(Last) (First) (Middle)

C/O VENTAS, INC.

300 NORTH LASALLE ST., SUITE 1600

(Street)

CHICAGO IL 60654

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ventas, Inc. [ VTR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CFO

3. Date of Earliest Transaction (Month/Day/Year)
11/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/12/2025		M		33,591(1)	A	$73.71	201,955	D
Common Stock	11/12/2025		S		33,591(1)	D	$76.7719(2)	168,364	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$73.71	11/12/2025		M			33,591(1)	08/03/2016(3)	08/03/2026	Common Stock	33,591	$0	0	D

Explanation of Responses:

1. The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025.

2. The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $76.71 to $76.9376 inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Fully vested.

Remarks:

	Robert F. Probst, By: /s/ Kenneth Hagan, Attorney-In-Fact	11/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.